Massachusetts Financial Services
SRPT icon

Massachusetts Financial Services’s Sarepta Therapeutics SRPT Stock Holding History

Massachusetts Financial Services’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-19,301
Closed -$330K – 915
2025
Q2 		$330K Buy
+19,301
New +$823K ﹤0.01% 860
2020
Q2 		– Sell
-60,158
Closed -$5.88M – 840
2020
Q1 		$5.88M Sell
60,158
-1,364
-2% -$156K ﹤0.01% 630
2019
Q4 		$7.94M Buy
61,522
+19
+0% +$1.92K ﹤0.01% 620
2019
Q3 		$4.63M Sell
61,503
-230
-0.4% -$27.2K ﹤0.01% 661
2019
Q2 		$9.38M Buy
+61,733
New +$7.5M ﹤0.01% 629

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Massachusetts Financial Services's SRPT Position: Q3 2025 in Review

Massachusetts Financial Services sold out of Sarepta Therapeutics (SRPT) in Q3 2025, closing a stake of 19,301 shares — an estimated $330K sold.

Massachusetts Financial Services first reported a position in SRPT in Q2 2019 and held it in 5 quarters. The position peaked at $9.38M in Q2 2019. 319 funds tracked by Wall St. Rank hold SRPT as of Q3 2025.

  • Massachusetts Financial Services reported no remaining Sarepta Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Massachusetts Financial Services sold 19,301 Sarepta Therapeutics shares in Q3 2025, an estimated $330K.
  • Massachusetts Financial Services first reported a position in Sarepta Therapeutics in Q2 2019 and held it in 5 quarters.
  • Massachusetts Financial Services's Sarepta Therapeutics position peaked at $9.38M in Q2 2019.
  • 319 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2025.

Based on Massachusetts Financial Services's 13F filing for Q3 2025, filed 29 Oct 2025.